14 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... (Anorexia) • Night ... Tuberculosis Treatment ... #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... (Anorexia) • Night ... Tuberculosis Treatment ... #Diagnosis #Management ... #Treatment #ActiveTB
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Diagnosis and Management ... polymicrobial infection ... Lung Abscess Pathophysiology ... degrees • Chills, night ... westermani • Other: TB
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Individualized Treatment ... are contacts of infectious ... 1: Choose one later-generation ... Tuberculosis #MDRTB #management ... #regimens #pharmacology
Rhabdomyolysis - Differential Diagnosis and Management Summary

Trauma:
 • Immobilization, Crush iniury, Compartment syndrome, Electrical injury
Exertional:
 •
Diagnosis and Management ... Statins), ETOH Infection ... Dermatomyositis) AKI - Pathophysiology ... oxidative iniury Treatment ... Iinitial rate: 1
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
(<100), except TB ... TB - Lymphadenitis ... survival) • TB ... initiated within eight ... Differential #Diagnosis #Management
Transverse Myelitis Overview

Focal inflammatory disorder of the spinal cord resulting in rapid onset of weakness, sensory
monophasic Pathophysiology ... Hyperreflexia develops later ... , Hep A/B/CMV, TB ... Transverse Myelitis Treatment ... Myelitis #diagnosis #management
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis Infection ... a person with infectious ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
effective for treatment ... Therapy—For Immediate Sight ... control of the infection ... #management #opportunistic ... #pharmacology
IDSA Recommendations for Treating Treponema pallidum Infections (Syphilis) to Prevent Disease in HIV-AIDS
Early Stage (Primary, Secondary,
1 dose (BII) Late-Latent ... 28 days (BIII) Late-Stage ... IDSA #Prevention #Treatment ... #management #opportunistic ... #pharmacology